nei nei nei nei
nei nei nei nei
nei Stephen M. Stahl, MD, PhD (Chair)
Adjunct Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA
Honorary Visiting Senior Fellow, University of Cambridge, Cambridge, UK
Director of Psychopharmacology, California Department of State Hospitals, Sacramento, CA

Dr. Stahl has held faculty positions at Stanford University, the University of California at Los Angeles, the Institute of Psychiatry London, the Institute of Neurology London, and, currently, as professor at the University of California at San Diego and as Honorary Fellow in Psychiatry at the University of Cambridge.

Dr. Stahl serves as editor-in-chief of CNS Spectrums. Author of over 500 articles and chapters, and more than 1600 scientific presentations and abstracts, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has written 35 textbooks and edited a dozen others, including the best-selling and award winning textbook, Stahl’s Essential Psychopharmacology, now in its fourth edition and the best-selling and award winning clinical manual, Essential Psychopharmacology Prescriber’s Guide, now in its fifth edition.

Recently, Dr. Stahl has published his first novel, Shell Shock, a thriller that recounts the history of PTSD (post-traumatic stress disorder). Dr. Stahl is also Senior Academic Advisor and Director of Psychopharmacology for the California Department of State Hospitals (DSH) where he has a leadership role in addressing violence in the eight-hospital 6500 patient DSH. He has been awarded the International College of Neuropsychopharmacology (CINP) Lundbeck Foundation Award in Education for his contributions to postgraduate education in psychiatry and neurology. His books have won the British Medical Association’s Book of the Year Award. Dr. Stahl is also the winner of the A.E. Bennett Award of the Society of Biological Psychiatry, the APA/San Diego Psychiatric Society Education Award, the UCSD Psychiatry Residency Teaching Award, and has been cited as both one of “America’s Top Psychiatrists” and one of the “Best Doctors in America.” He was honored with the Distinguished Psychiatrist Award of the APA and gave the Distinguished Psychiatrist Lecturer for 2013. He was named the 2016 David Mrazek Award Winner of the American Psychiatric Association and gave the Mrazek Pharmacogenomics Memorial Lecture at the 2016 APA meeting.

nei Andrew J. Cutler, MD
Chief Medical Officer, Meridien Research Group, Tampa, FL
CEO and CMO, Florida Clinical Research Center, LLC, Bradenton, FL

Dr. Cutler is the Chief Medical Officer of Meridien Research Group in Tampa, FL, and he is also CEO & Chief Medical Officer of Florida Clinical Research Center in Bradenton. Dr Cutler received his medical degree from the University of Virginia School of Medicine and continued his medical training at the University of Virginia Medical Center where he served as an intern, resident, and chief resident in Psychiatry and Internal Medicine. While at the University of Virginia, he also completed training in dopamine receptor pharmacology and clinical psychopharmacology research. He then served as a Legislative Fellow and Mental Health Advisor to US Senator Paul Wellstone in the 103rd U.S Congress.

He has devoted more than 20 years to clinical research, and he has been principal investigator on more than 400 psychiatric and medical clinical trials. He has also published more than 60 peer-reviewed articles, presented over 100 abstracts at national and international medical meetings, and he has given hundreds of invited CME and promotional talks around the world.

He regularly speaks to professional and community audiences about the evaluation and treatment of mental illnesses such as ADHD, anxiety disorders, bipolar disorder, depression, and schizophrenia. He has received several professional honors and awards, including the Merck Award for outstanding medical scholarship, the University of Virginia Pride Award for outstanding patient care, the William Sorum Award from the American Psychiatric Association, the Effective Legislative Fellow Award from the National Alliance for the Mentally Ill, the Distinguished Clinical Professional Award from the Mental Health Association of Central Florida, and he was chosen by his peers as the best psychiatrist in Orlando 5 years in a row (2003-2007).

Dr. Cutler is a Fellow of the American Psychiatric Association and the Academy of Psychosomatic Medicine, and holds the Certified Physician Investigator (CPI) distinction from the Academy of Physicians in Clinical Research.

nei Daniel E. Diamond, MD
Founder, NogginStorm, LLC, Bremerton, WA
Assistant Clinical Professor, University of Washington School of Medicine, Seattle, WA
Founder/Director, The Christian Medical Response Team, Silverdale, WA

Well known for creating an exciting learning experience, Dr. Diamond engages the mind of the learner leaving participants with practical concepts they will never forget. Dr. Diamond founded and serves as the Director of the Nation’s first state-affiliated medical disaster response team. He has responded to a variety of international disasters and most recently he served as the Medical Director for Medical Teams International’s First Response Team to Haiti. Following Hurricane Katrina, he played a strategic role as Director of the Mass Casualty Triage Unit at the New Orleans Convention Center. He has been interviewed on CNN, Larry King Live and Anderson Cooper. He is a member of the National Speakers Association and served as President of NSA Northwest from 2011-2012.

As an experienced family physician and an award-winning educator, Dr. Diamond delivers practical information with creativity and skill. Participants experience learning through a variety of effective strategies that foster rapid mastery of new information. After earning his medical degree from University of Washington, Dr. Diamond completed his residency in Family Medicine in Milwaukee, WI. The American Academy of Family Physicians awarded Dr. Diamond the degree of Fellow and he is Board Certified with the American Board of Family Physicians. He is a member of the Editorial Board for the Primary Care Companion to the Journal of Clinical Psychiatry. Dr. Diamond is also a Clinical Assistant Professor at the University of Washington School of Medicine.

In 2010, the American Red Cross gave him the “Real Hero” award and he also received the Washington State Governor’s Award of Excellence for his work in Haiti. In 2014, Dr. Diamond received the Presidents Volunteer Service Award from President Obama and he also received the Quality of Care Lifetime Achievement Award, Healthcare Heroes.

nei David W. Goodman, MD, FAPA
Director, Adult Attention Deficit Disorder Center of Maryland, Baltimore, MD
Director, Suburban Psychiatric Associates, LLC, Baltimore, MD
Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD

David W. Goodman, MD, is Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. He is also Director of the Adult Attention Deficit Disorder Center of Maryland in Lutherville and Director of Suburban Psychiatric Associates, LLC.

A 1983 graduate of Albany Medical College of Union University, Dr. Goodman completed a medical/psychiatric internship at Baltimore City Hospital and his psychiatric residency at The Johns Hopkins Hospital in 1986.

Dr. Goodman has continued a full time clinical practice focusing on the diagnosis and treatment of mood disorders, adult Attention Deficit/Hyperactivity Disorder, Anxiety Disorders. For almost 30 years, he has been teaching psychiatric residents at The Johns Hopkins Hospital. Dr. Goodman has presented over 600 lectures to primary care physicians, psychiatrists, medical specialists and the general public. His psychiatric commentary has been featured on national (ABC World News, CNN Anderson Cooper 360, ESPN Sports Center) and regional television around the country, PBS and national affiliate stations, national magazines (U.S. News and World Report, Wall Street Journal, New York Times, USA Weekend Magazine, Boston Globe, BusinessWeek) and radio interviews around the country. Dr. Goodman has been an ADHD consultant to Major League Baseball and is now a consultant to the National Football League.

Dr. Goodman has been a Principal Investigator for multi-site Phase II and III drug trials for the treatment of adult Attention Deficit/Hyperactivity Disorder and Major Depression. Dr. Goodman is the lead author on the largest adult ADHD trial published and the lead author on the largest survey assessment of physician clinical practice for adults with ADHD. He has published articles in peer-reviewed journals, authored four book chapters and The Black Book of ADHD. He serves as a prepublication peer reviewer for several national and international psychiatric journals. He continues to treat patients in a full time clinical practice.

nei Roger S. McIntyre, MD, FRCPC
Professor, Departments of Psychiatry and Pharmacology; Head, Mood Disorders Psychopharmacology Unit, University Health Network; University of Toronto, ON, Canada

Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada.

Dr. McIntyre was named by Thomson Reuters in 2014 and 2015, as one of “The World’s Most Influential Scientific Minds”. This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.

Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.

Dr. McIntyre is extensively involved in medical education. He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.

Dr. McIntyre is a contributor to the Florida Medicaid Drug Therapy Management Program for Behavioral Health Guidelines for the treatment of adults with Major Depressive Disorder and Bipolar Disorder. Dr. McIntyre is also the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders. Dr. McIntyre has published hundreds of peer-reviewed articles and has edited and/or co-edited several textbooks on mood disorders.

Dr. McIntyre completed his medical degree at Dalhousie University. He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.

nei Mary D. Moller, DNP, ARNP, PMHCNS-BC, CPRP, FAAN
Associate Professor, Pacific Lutheran University School of Nursing, Tacoma, WA
Director of Psychiatric Services, Northwest Center for Integrated Health, Tacoma, WA

Dr. Mary D. Moller, DNP, ARNP, PMHCNS-BC, CPRP, FAAN is an internationally known psychiatric mental health nurse clinician, researcher, educator, and presenter. She is an advanced registered nurse practitioner who is dually certified as a clinical specialist in adult psychiatric-mental health nursing and a psychiatric rehabilitation practitioner. She is an Associate Professor at Pacific Lutheran University in Tacoma, WA where she is coordinator of the psychiatric nurse practitioner Doctor of Nursing Practice program. Her teaching foci include psychopharmacology, psychopathology, group therapy, 1:1 psychotherapy, mental health assessment and advanced practice nursing including legislative activity related to independent practice.

She is also the Director of Psychiatric Services for Northwest Center for Integrated Health in Tacoma, WA where she is in practice as a psychiatric ARNP treating patients in a triple integration agency: substance abuse, mental illness, and primary care. She is implementing psychiatric wellness protocols for relapse prevention across the three disciplines.

From January 2009-August, 2014 she was Director of the Psychiatric-Mental Health Nurse Practitioner specialty at the Yale University School of Nursing. While in Connecticut, Mary was in practice as an APRN at Yale Behavioral Health of Hamden, an outpatient mental health center that served patients with co-occurring disorders.

From 1993-2008 she was owner and Clinical Director of The Suncrest Wellness Center, located in Spokane, WA, the first independent nurse managed owned and operated rural outpatient psychiatric clinic in the United States. Suncrest was featured with Patty Duke on Good Morning America. In addition to her administrative duties and ongoing program research and QI activities, she managed a full caseload of over 300 patients where she was responsible for primary mental health care including prescribing and monitoring psychotropic medications, conducting group therapy, and group psychoeducation on recovery from trauma, relapse prevention, and recovery from psychosis.

She has published over 100 peer-reviewed articles, book chapters, policy statements, conference proceedings, newsletter articles, training manuals, and professional videotapes. She is the producer and director of the award winning Understanding and Communicating With video series that has four videos. Mary has authored two books including a Mosby pharmacology review book and a new undergraduate psychiatric nursing textbook published by Pearson in January 2015 titled Psychiatric-Mental Health Nursing: From Suffering to Hope.

She is currently the first nurse to serve as an Associate Editor of Clinical Psychiatry. She has served on the editorial boards of The Journal of the American Psychiatric Nurses Association, Philosophy and Ethics in Healthcare and Medicine, Psychiatric Rehabilitation Journal; a journal of the National Alliance For The Mentally Ill And The Center For Psychiatric Rehabilitation at Boston University, The Journal of the California Alliance for the Mentally Ill, and Directions In Psychiatric Nursing.

She is currently a reviewer for Archives in Psychiatric Nursing, Journal of the American Psychiatric Nurses Association, Qualitative Health Research, Journal of Midwifery and Womens Health, and Perspectives in Psychiatric Care.

She has made over 1000 professional and research presentations in all 50 states, Alberta, Australia, British Columbia, China, Cuba, England, Denmark, Hong Kong, Israel, Ontario, Singapore, and Quebec. She has received numerous awards including induction as a Fellow in the American Academy of Nursing, President of the American Psychiatric Nurses Association, Distinguished Service Award from the American Psychiatric Nurses Association, Distinguished Alumnus from the University of Nebraska College of Nursing Medical Center, Award for Clinical Excellence from the American Psychiatric Nurses Association, and the AAPPN Award for Clinical Excellence. She was Co-PI and Curriculum co-coordinator for a 5-year SAMHSA grant through the APNA entitled Recovery to Practice. She is currently President-Elect of the Washington State Association of Advanced Practice Psychiatric Nurses. She is also the current ANA representative to the JCAHO Psychiatric Professional and Technical Advisory Committee.

Her research interests include psychological adjustment to and symptom management in recovery from schizophrenia, a wellness approach to symptom management of recovery from trauma and abuse, and most recently identification of motivational strategies for nurse recruitment and retention based on self-determination theory. From 2009-2014 she served as part of the grant writing team and curriculum co-chair for the SAMHSA Recovery to Practice project with the American Psychiatric Nurses Association.

She is the co-developer of the Murphy-Moller Wellness Model that serves as the centerpiece of the Three R’s Psychiatric Rehabilitation Recovery Program. Rehospitalization rates for participants with serious mental illness enrolled in the program are reduced by 93.5%. These results have been replicated nationally and internationally.

nei William M. Sauvé, MD
Medical Director, TMS NeuroHealth Centers of Richmond and Charlottesville, Glen Allen and Charlottesville, VA

William M. Sauvé, MD, received his medical degree from the Uniformed Services University of the Health Sciences in Bethesda, Maryland, and completed his residency in adult psychiatry at the National Capitol Consortium in Washington, DC, prior to deploying to the Al Anbar Province, Iraq, as the Regimental Psychiatrist for the 7th Marines.

After eleven years of active duty service, Dr Sauvé left the United States Navy to become the Clinical Director of the Military Program at Poplar Springs Hospital in Petersburg, VA, an inpatient structured program for the treatment of Posttraumatic Stress Disorder and Chemical Dependency that caters exclusively to the military population. In 2014, he left Poplar Springs Hospital to focus on Transcranial Magnetic Stimulation and now serves as the Medical Director for TMS NeuroHealth Centers in Richmond (Glen Allen) and Charlottesville, VA. Dr Sauvé also consults for pharmaceutical companies and associated industries as well.

He is a member of the American Psychiatric Association, and certified by the American Board of Psychiatry and Neurology. Dr Sauvé also recently co-authored “Psychopharmacological Treatment,” with Dr Stahl, a chapter in Treating PTSD in Military Personnel, edited by Bret Moore and Walter Penk.

nei Thomas L. Schwartz, MD
Professor and Vice Chair, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY

Thomas L. Schwartz, MD, completed his MD and residency at SUNY Upstate Medical University in Syracuse, NY. Dr. Schwartz currently provides medical student and resident administration, supervision, lectures, and directs CME events for the psychiatry department at SUNY Upstate. Dr. Schwartz maintains a small private practice and consults for the Indian Health Service.

He is integrally active in curriculum reform at SUNY Upstate and sits on many academic committees. He has been recognized with the Marc H. Hollander, MD, Psychiatry Award, Teacher of the Year, and Mentor of the Year awards from SUNY Upstate; Nancy Roeske, MD, Irma Bland, Certificates of Recognition for Excellence in Medical Student and Resident Education from the APA, the SUNY Upstate President's Award and Chancellor's Awards for Teaching.

He has served as principle investigator on clinical trials, co-authored Case-Studies: Stahl's Essential Psychopharmacology: Volume 2 and Integrating Psychotherapy and Psychopharmacology, published articles in medical journals, and served as peer reviewer for U.S. and international journals.